Keywords: Allergan, Fiancial results, Third-quarter 2012, Options for obesity interventions business

Allergan 4th-qtr revenues up 6%; earnings exceed expectations

Article | 31 October 2012

US health care firm Allergan (NYSE: AGN) revealed yesterday that revenues for its fiscal fourth-quarter ended September 30, 2012, rose 6% to $1.41 billion, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Allergan

Go to company listing